Holy Cross Hospital Holy Cross (2) is a clinical research site located in Silver Spring, Maryland, United States 20910.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
Holy Cross Hospital Holy Cross (2) has participated in 1 clinical trials.
Therapeutic areas: Tumors With Aberrations in ALK or ROS1.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Holy Cross Hospital Holy Cross (2) has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Holy Cross Hospital Holy Cross (2) has 1 clinical trials on record. Their work covers Tumors With Aberrations in ALK or ROS1.
Holy Cross Hospital Holy Cross (2) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.